16 Feb | Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) National Institutes of Health This Trailblazer Award is an opportunity for NIH-definedNew and Early Stage Investigatorsto pursue research programs that integrate engineering and the physical sciences with the life and/or biomedical sciences. A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Importantly, applicants must propose research approaches for which there are minimal or no preliminary data.